The Current Ratio as of December 2024 (TTM) for Catalyst Pharmaceuticals, Inc. (CPRX) is 5.11

According to Catalyst Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.11. This represents a change of 12.26% compared to the average of 4.56 of the last 4 quarters.

Catalyst Pharmaceuticals, Inc. (CPRX) Historical Current Ratio (quarterly & annually)

How has CPRX Current Ratio performed in the past?

The mean historical Current Ratio of Catalyst Pharmaceuticals, Inc. over the last ten years is 9.83. The current 5.11 Current Ratio has changed 5.10% with respect to the historical average. Over the past ten years (40 quarters), CPRX's Current Ratio was at its highest in in the March 2018 quarter at 28.90. The Current Ratio was at its lowest in in the December 2023 quarter at 2.88.

Catalyst Pharmaceuticals, Inc. (CPRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Catalyst Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Catalyst Pharmaceuticals, Inc. (CPRX) Average Current Ratio

How has CPRX Current Ratio performed in the past?

The current Current Ratio of Catalyst Pharmaceuticals, Inc. (CPRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Catalyst Pharmaceuticals, Inc. (CPRX) Current Ratio vs. Peers

How is CPRX’s Current Ratio compared to its peers?

Catalyst Pharmaceuticals, Inc.’s Current Ratio is less than Day One Biopharmaceuticals, Inc. (14.62), less than Terns Pharmaceuticals, Inc. (32.99), greater than X4 Pharmaceuticals, Inc. (4.89), less than Inozyme Pharma, Inc. (7.68), less than Mereo BioPharma Group plc (6.10), greater than Exelixis, Inc. (3.93), greater than TG Therapeutics, Inc. (4.59), less than Viking Therapeutics, Inc. (36.47), less than Madrigal Pharmaceuticals, Inc. (5.98), greater than BioXcel Therapeutics, Inc. (1.87), greater than Axsome Therapeutics, Inc. (2.44), greater than Incyte Corporation (1.87), less than ImmunoGen, Inc. (5.47), greater than Sarepta Therapeutics, Inc. (3.84), greater than ACADIA Pharmaceuticals Inc. (2.29), greater than Intercept Pharmaceuticals, Inc. (4.22), greater than Hepion Pharmaceuticals, Inc. (1.30), less than Akero Therapeutics, Inc. (17.25), less than Reata Pharmaceuticals, Inc. (6.75),

Build a custom stock screener for Catalyst Pharmaceuticals, Inc. (CPRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Catalyst Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Catalyst Pharmaceuticals, Inc. (CPRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Catalyst Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.